sh-CTSS/sh-BRCA1 group showed less tumor delayed response than that of sh-CTSS alone xenografted group, suggesting antitumor effects by CTSS inhibition is occurred only in the presence of functional BRCA1. Here, BRCA1 is linked to neoplasm.